Philippe JEAN-PIERRE

---

• Type de publi. : Article dans une revue
• Date de publi. : 31/10/2021
• Auteurs : Guillaume AussedatDelphine Maucort-BoulchPhilippe ReyViolaine SafarLionel KarlinMad Helenie ElsensohnEmmanuel BachyLaure LebrasBertrand FavierNicolas VantardDana GhergusCamille GolfierPierre SesquesAnne LazarethHélène LequeuEmmanuelle FerrantGilles SallesEmmanuelle Nicolas-VirelizierHervé Ghesquières
• Organismes : Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL] Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 Hospices Civils de Lyon Service de Biostatistiques [Lyon] Centre Léon Bérard [Lyon] UNICANCER Centre Hospitalier Lyon Sud [CHU - HCL] Centre Hospitalier Lyon Sud [CHU - HCL] Hospices Civils de Lyon Centre Hospitalier Lyon Sud [CHU - HCL] Université Claude Bernard Lyon 1 Immuno-Biologie des Lymphomes [CIRI] Centre Léon Bérard [Lyon] Groupe de Recherche et d’Étude du Processus Inflammatoire Service d'Oncologie Médicale [Centre hospitalier Lyon Sud - HCL] Immunologie, Immunopathologie et Chimie Thérapeutique Immunopathologie et chimie thérapeutique Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL] Hospices Civils de Lyon Centre Hospitalier Lyon Sud [CHU - HCL] Centre Hospitalier Lyon Sud [CHU - HCL] French Innovative Leukemia Organization Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL] Hospices Civils de Lyon Université de Lyon Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL] Centre Léon Bérard [Lyon] Centre de Recherche en Cancérologie de Lyon Immuno-Biologie des Lymphomes [CIRI] Service d’Hématologie [Centre Hospitalier Lyon Sud - HCL]
• Publié dans Leukemia & lymphoma le 27/10/2020

---

Source

---

• Type de publi. : Pré-publication, Document de travail
• Date de publi. : 29/10/2021
• Auteurs : Michel AractingiPierre-Alexandre LeziartThomas FlayolsJulien PerezTomi SilanderPhilippe Souères
• Organismes : Naver Labs Europe [Meylan] Équipe Mouvement des Systèmes Anthropomorphes Équipe Mouvement des Systèmes Anthropomorphes Équipe Mouvement des Systèmes Anthropomorphes Naver Labs Europe [Meylan] Naver Labs Europe [Meylan] Équipe Mouvement des Systèmes Anthropomorphes

---

Résumé : Predefined gait patterns for quadruped locomotion can hardly be optimal in all situations with regard to stability, cost of transport and velocity tracking error. Hence, in this work, we tackle the challenge of adapting a predefined trotting gait, implemented in the model-based controller of Solo, to optimize both energy consumption and velocity tracking. To this end, we propose a model-free reinforcement learning method for adapting the timings of the contact/swing phases for each foot. The learned agent augments a control pipeline that was previously developed for the Solo robot. We also propose to use a self-attention mechanism over the history of states in order to extract useful information for adapting the gait. Through a comprehensive set of experiments, we demonstrate how, compared to the nominal gait, our method significantly reduces energy consumption, better tracks the desired velocity, and makes it possible to reach higher speeds. A video of the method is found at https://youtu.be/ykbDUyASXs4.

---

Fichiers liés : ICRA2022(5).pdf

---

Source

---

• Type de publi. :
• Date de publi. : 28/10/2021
• Auteurs : Louise TarradeJean-Pierre ChevrotJean-Philippe Magué
• Organismes : Interactions, Corpus, Apprentissages, Représentations LInguistique et DIdactique des Langues Étrangères et Maternelles Interactions, Corpus, Apprentissages, Représentations Institut Rhône-Alpin des systèmes complexes

---

Résumé : The diffusion process of linguistic innovations has long been a topic of interest in sociolinguistics (Weinreich et al., 1968) and many studies have highlighted the influence of social structures on change (Labov, 2001; Milroy & Milroy, 1997). The recent access to massive social network data and the advent of computational sociolinguistics (Nguyen et al., 2016) allow an approach to this phenomenon that combines a large amount of data and a fine-grained temporality. Using methods from both computational sociolinguistics and network science, we focus on the diffusion of lexical innovations and we ask what differentiates, after an expansion phase, those that stabilize within our observation period from those that are eventually abandoned. In particular, we examine the impact of the social structure of linguistic communities on these diffusion and acceptance processes. We rely on a corpus of French tweets, that spans from 2012 to 2019 and includes about 600 million tweets from more than two million users. Based on the evolution over time of the rate of use of each linguistic form, we select those that appear during the period covered by the corpus and then we distinguish the forms that stabilize from those that eventually die out. By modeling the trajectories, we then identify the three characteristic periods of the diffusion of an innovation (Fagyal et al., 2010). Finally, by establishing the network of contact between users on the basis of their followers and followees, we examine the circulation of forms between them at different periods, and identify factors that condition the stabilization or not of innovations. This poster will present the methodologies used to identify linguistic innovations and to model their trajectory. We will also present the first results on the connection between the evolution of forms and the structure of the contact network.

---

Source

---

• Type de publi. : Article dans une revue
• Date de publi. : 28/10/2021
• Auteurs : Emmanuel Happi NgankouBenjamin GoryGaultier MarnatSébastien RichardRomain BourcierIgor SibonCyril DargazanliCaroline ArquizanBenjamin MaïerRaphaël BlancBertrand LapergueArturo ConsoliStéphane VannierLaurent SpelleChristian DenierMarion BoulangerMaxime GaubertiSuzana SalemeFrancisco MacianFrédéric ClarençonCharlotte RossoOlivier NaggaraGeorgios TsivgoulisOzlem Ozkul-WermesterChrysanthi PapagiannakiAlain ViguierChristophe CognardAnthony LebrasSarah EvainValérie WolffRaoul PopSerge TimsitJean Christophe GentricFrédéric BourdainLouis VeunacFrançois EugèneStephanos Nikolaos FinitsisMichel P. PiotinHocine RedjemSimon EscalardJean Philippe DessillesFrançois DelvoyeStanislas SmajdaHebert SolèneMikaël MazighiMikael ObadiaCandice SabbenPierre SenersIgor RaynouardOvide CorabianuThomas de BrouckerEric ManchonGuillaume TaylorMalek Ben MaachaLaurie Anne ThionAugustin LeclerJulien SavatovsjyFoch HospitalAdrien WangSerge EvrardMaya TchikviladzeNadia AjiliDavid WeisenburgerlileLucas GorzaGéraldine BuardOguzhan CoskunFederico Di MariaGeorges RodeshSergio ZimatoreMorgan LeguenJulie GratieuxFernando PicoHaja RakotoharinandrasanaPhilippe TassanRoxanna PollSylvie MarinierFlorent GarielXavier BarreauJérôme BergePatrice MenegonLudovic LucasStéphane OlindoPauline RenouSharmila SagnierMathilde PoliSabrina DebruxellesFrançois RouanetThomas TourdiasJean Sebastien LiegeyPierre BriauNicolas PangonLili DetrazBenjamin Daumas-DuportPierre Louis AlexandreMonica RoyCédric LenobleHubert Armand DesalBenoît GuillonSolène de GaalonCécile PreterreSerge BracardRené AnxionnatMarc BraunAnne Laure DerelleTonnelet RomainLiang LiaoFrançois ZhuEmmanuelle SchmittSophie PlanelLisa HumbertjeanGioia MioneJean Christophe LacourNolwenn Riou-ComteGérard AudibertMarcela VoicuLionel AlbMarie ReitterMadalina BrezeanuAgnès MassonAdriana TabarnaIona PodarSarah GuyFatiha BechiriPauline BourstFrancisco Macian-MontoroSuzanna SalemeCharbel MounayerAymeric RouchaudLaetitia GimenezAlexandre CosnardVincent CostalatGrégory GascouPierre Henri LefèvreImad DerrazCarlos RiquelmeNicolas GaillardIsabelle MourandLucas CortiFederico CagnazzoAdrien ter SchiphorstJean-Christophe FerréHélène RaoultThomas RonziereMaria LassaleChristophe PayaJean Yves GauvritClément TracolSophie Langnier-LemercierAxelle MauriceSabrina CochennecMélanie PinaultEimad ShotarNader Antoine SourourStéphanie LenckKévin PrematYves Samson Anne LégerSophie CrozierFlore BaronnetSonia AlamowitchLaure BottinMarion YgerVincent DegosOlivier ChassinVanessa ChalumeauJildaz CaroffLaura VendittiMariana SarovNicolas LegrisOlivier NaggaraWagih Ben HassenGrégoire BoulouisChristine Rodriguez-RégentDenis TrystramBasile KerlerouxValérie DomigoCatherine LamyJulia BirchenallClothilde IsabelFrançois LunChristophe CognardAnne Christine JanuelJean Marc OlivotLouis FontaineNicolas RaposoFabrice BonnevilleJean-François AlbucherLionel CalviereJean DarcourtGuillaume BellangerPhilippe TallEmmanuel TouzéCharlotte BarbierRomain SchneckenburgerJulien CogezSophie GuettierJulien OgnardFrançois Mathias MerrienOzlem Ozku WermesterEvelyne Guégan MassardierAude Bagan TriquenotMargeaux LefebvrePatricia BernadyLaurent Lagoarde-SegotHélène CailliezDavid HigueVéronique QuenardelleValérie LauerRoxana GheocaIrène Nora Pierre-PaulRemy BeaujeuxDan MihocMonica ManisorJulien PottecherAlain MeyerThiên-Nga Chamaraux-TranAnthony Le BrasArnaud Le Guen
• Organismes : Département de neuroradiologie diagnostique et thérapeutique [CHRU Nancy] Imagerie Adaptative Diagnostique et Interventionnelle Centre Hospitalier Universitaire de Bordeaux Service de neurologie [CHRU Nancy] Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] Défaillance Cardiovasculaire Aiguë et Chronique Centre Hospitalier Universitaire de Nantes = Nantes University Hospital Centre Hospitalier Universitaire de Bordeaux Neuroradiologie [Hôpital Gui de Chauliac] Hôpital Gui de Chauliac [CHU Montpellier] CHU Rothschild [AP-HP] CHU Rothschild [AP-HP] Service Neuroradiologie diagnostique et interventionnelle [Hôpital Foch] UFR Sciences de la santé Simone Veil Service Neuroradiologie diagnostique et interventionnelle [Hôpital Foch] UFR Sciences de la santé Simone Veil Service de Neurologie [CHU Rennes] Service de Neuroradiologie [CHU de Bicêtre] Service de neurologie [Le Kremlin Bicêtre] Service de Neurologie [CHU Caen] Départment de Neuroradiologie [CHU Caen] Service de Neuroradiologie interventionnelle [CHU Limoges] Service de Neurologie [CHU Limoges] CHU Pitié-Salpêtrière [AP-HP] CHU Pitié-Salpêtrière [AP-HP] Service de Neurologie [CH Saint-Anne] Service de Neurologie [CH Saint-Anne] Service de neurologie [Rouen] Département de Neuroradiologie [CHU Rouen] Département Neurologie [CHU Toulouse] Service Neuroradiologie Diagnostique et Thérapeutique [CHU Toulouse] Service de radiologie [Vannes] Service de radiologie [Vannes] Service de Neurologie [Strasbourg] Département de Neuroradiologie [Strasbourg] Service de Neurologie [Brest] Service de Neuroradiologie [Brest] Neurologie - Côte Basque Neurologie - Côte Basque Service de Neurologie [CHU Rennes] Aristotle University of Thessaloniki Neuroimagerie: méthodes et applications
• Publié dans Stroke le 31/10/2020

---

Résumé : BACKGROUND AND PURPOSE: Procedural complications in thrombectomy for large vessel occlusions of the anterior circulation are not well described. We investigated the incidence, risk factors, and clinical implications of thrombectomy complications in daily clinical practice. METHODS: We used data from the ongoing prospective multicenter observational Endovascular Treatment in Ischemic Stroke Registry in France. The present study is a retrospective analysis of 4029 stroke patients with anterior large vessel occlusions treated with thrombectomy between January 2015 and May 2020 in 18 centers. We systematically collected procedural data, incidence of embolic complications, perforations and dissections, clinical outcome at 90 days, and hemorrhagic complications. RESULTS: Procedural complications occurred in 7.99% (95% CI, 7.17%–8.87%), and embolus to a new territory (ENT) was the most frequent (5.2%). Predictors of ENTs were terminal carotid/tandem occlusion (odds ratio [OR], 5 [95% CI, 2.03–12.31]; P<0.001) and an increased total number of passes (OR, 1.22 [95% CI, 1.05–1.41]; P=0.006). ENTs were associated to worse clinical outcomes (90-day modified Rankin Scale score, 0–2; adjusted OR, 0.4 [95% CI, 0.25–0.63]; P<0.001), increased mortality (adjusted OR, 1.74 [95% CI, 1.2–2.53]; P<0.001), and symptomatic intracerebral hemorrhage (adjusted OR, 1.87 [95% CI, 1.15–3.03]; P=0.011). Perforations occurred in 1.69% (95% CI, 1.31%–2.13%). Predictors of perforations were terminal carotid/tandem occlusions (39.7% versus 27.6%; P=0.028). 40.7% of patients died at 90 days, and the overall rate of poor outcome was 74.6% in case of perforation. Dissections occurred in 1.46% (95% CI, 1.11%–1.88%) and were more common in younger patients (median age, 64.2 versus 70.2 years; P=0.002). Dissections did not affect the clinical outcome at 90 days. Besides dissection, complications were independent of the thrombectomy technique. CONCLUSIONS: Thrombectomy complication rate is not negligible, and ENTs were the most frequent. ENTs and perforations were associated with disability and mortality, and terminal carotid/tandem occlusions were a risk factor.

---

Source

---

• Type de publi. : Article dans une revue
• Date de publi. : 28/10/2021
• Auteurs : Jean-Christophe CorvolJean‐philippe AzulayBjörn BosseYves DauvilliersLuc DefebvreFabian KlostermannNorbert KovacsDavid MaltêteWilliam G OndoRajesh PahwaWerner ReinStéphane ThoboisMartin ValisAleksandar VidenovicOlivier J. Rascol
• Organismes : Institut du Cerveau = Paris Brain Institute NS-Park/FCRIN Network Institut de Neurosciences de la Timone NS-Park/FCRIN Network Hôpital Gui de Chauliac [CHU Montpellier] CHU Montpellier = Montpellier University Hospital Université de Montpellier Département de neurologie [Lille] NS-Park/FCRIN Network Charité - UniversitätsMedizin = Berlin University Medicine University of Pécs Medical School Service de neurologie [Rouen] NS-Park/FCRIN Network Center for neurogenetics [Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York] University of Kansas Medical Center [Kansas City, KS, USA] Theranexus [Lyon] Institut des sciences cognitives Marc Jeannerod - Centre de neuroscience cognitive - UMR5229 Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL] NS-Park/FCRIN Network Univerzita Karlova [Praha, Česká republika] = Charles University [Prague, Czech Republic] Massachusetts General Hospital [Boston] Centre Hospitalier Universitaire de Toulouse NS-Park/FCRIN Network
• Publié dans Movement Disorders le 31/10/2020

---

Résumé : Background Excessive daytime sleepiness (EDS) is a frequent and disabling symptom of Parkinson's disease (PD) without approved treatment. THN102 is a novel combination drug of modafinil and low-dose flecainide. Objective The aim of this study is to evaluate the safety and efficacy of THN102 in PD patients with EDS. Methods The method involved a randomized, double-blind, placebo-controlled, crossover trial testing two doses of THN102 (200 mg/d modafinil with 2 mg/d [200/2] or 18 mg/d flecainide [200/18]) versus placebo; 75 patients were exposed to treatment. The primary endpoint was safety. The primary efficacy outcome was the change in Epworth Sleepiness Scale (ESS) score. Results Both doses of THN102 were well tolerated. ESS significantly improved with THN102 200/2 (least square means vs. placebo [95% confidence interval, CI]: −1.4 [−2.49; −0.31], P = 0.012) but did not change significantly with the 200/18 dosage. Conclusions THN102 was well tolerated and showed a signal of efficacy at the 200/2 dose, supporting further development for the treatment of EDS in PD. © 2021 International Parkinson and Movement Disorder Society

---

Fichiers liés : Corvol et al. - THN 102 for Excessive Daytime Sleepiness Associate.pdf

---

Source

---

• Type de publi. :
• Date de publi. : 27/10/2021
• Auteurs : Philippe DouchetJérôme BoissierStephen MuleroHubert FertéMargot DobervaJean-François AllienneEve ToulzaKévin BéthuneOlivier Rey
• Organismes : Interactions Hôtes-Pathogènes-Environnements Interactions Hôtes-Pathogènes-Environnements Interactions Hôtes-Pathogènes-Environnements Epidémiosurveillance de protozooses à transmission alimentaire et vectorielle Université de Reims Champagne-Ardenne Laboratoire de Biodiversité et Biotechnologies Microbiennes Interactions Hôtes-Pathogènes-Environnements Interactions Hôtes-Pathogènes-Environnements Diversité, adaptation, développement des plantes Interactions Hôtes-Pathogènes-Environnements

---

Fichiers liés : Douchet-2021-eags.pdf

---

Source

---

• Type de publi. : Article dans une revue
• Date de publi. : 26/10/2021
• Auteurs : Lucie Isoline PisellaSara FernandesGuilhem SoléTanya StojkovicCeline TardJean-Baptiste ChansonFrancoise BouhourEmmanuelle Salort-CampanaGuillemette BeaudonnetLouise DebergeFanny DuvalAude Marie GrapperonMarion MasingueAleksandra Nadaj-PaklezaYann PereonFrederique AudicAnthony BehinDiane FriedmanArmelle MagotJean Baptiste NourySarah SouvannanorathKarim WahbiJean Christophe AntoineKevin BigautJean-Philippe CamdessanchéPascal CintasRabab DebsCaroline Espil-TarisLaurent KremerThierry KuntzerPascal LaforetVincent LaugelMartial MallaretMaud MichaudSylvain NolletJuliette SvahnSavine VicartRocio Nur Villar-QuilesIsabelle DesguerreDavid AdamsSandrine Segovia-KuenyGeraldine MerretElhadi HammoudaAnnamaria MolonShahram Attarian
• Organismes : Assistance Publique - Hôpitaux de Marseille Assistance Publique - Hôpitaux de Marseille Groupe hospitalier Pellegrin CHU Pitié-Salpêtrière [AP-HP] Centre de recherche en Myologie – U974 SU-INSERM Centre Hospitalier Régional Universitaire [CHU Lille] Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 Centre Hospitalier Universitaire [Strasbourg] Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL] Hôpital de la Timone [CHU - APHM] Aix Marseille Université Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre] Groupe hospitalier Pellegrin Groupe hospitalier Pellegrin Hôpital de la Timone [CHU - APHM] Aix Marseille Université CHU Pitié-Salpêtrière [AP-HP] Centre de recherche en Myologie – U974 SU-INSERM Centre Hospitalier Universitaire [Strasbourg] Centre Hospitalier Universitaire de Nantes = Nantes University Hospital Hôpital de la Timone [CHU - APHM] CHU Pitié-Salpêtrière [AP-HP] Centre de recherche en Myologie – U974 SU-INSERM Hôpital Raymond Poincaré [AP-HP] Centre Hospitalier Universitaire de Nantes = Nantes University Hospital Centre Hospitalier Régional Universitaire de Brest CHU Henri Mondor [Créteil] Hôpital Cochin [AP-HP] Paris-Centre de Recherche Cardiovasculaire Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] Centre Hospitalier Universitaire [Strasbourg] Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] Centre Hospitalier Universitaire de Toulouse CHU Pitié-Salpêtrière [AP-HP] Centre Hospitalier Universitaire de Bordeaux Centre Hospitalier Universitaire [Strasbourg] Centre Hospitalier Universitaire Vaudois = Lausanne University Hospital [Lausanne] Hôpital Raymond Poincaré [AP-HP] Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées Centre Hospitalier Universitaire [Strasbourg] Centre Hospitalier Universitaire [CHU Grenoble] [GIN] Grenoble Institut des Neurosciences Centre Hospitalier Régional Universitaire de Nancy Centre Hospitalier Régional Universitaire de Besançon Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL] CHU Pitié-Salpêtrière [AP-HP] Centre de recherche en Myologie – U974 SU-INSERM CHU Pitié-Salpêtrière [AP-HP] Centre de recherche en Myologie – U974 SU-INSERM Hôpital Necker - Enfants Malades [AP-HP] Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre] Association française contre les myopathies Association française contre les myopathies Association française contre les myopathies Assistance Publique - Hôpitaux de Marseille Hôpital de la Timone [CHU - APHM]
• Publié dans Orphanet Journal of Rare Diseases le 27/10/2020

---

Résumé : Background: Due to their health condition, patients with neuromuscular diseases (NMD) are at greater risk of developing serious complications with COVID-19. The objective of this study was to analyze the prevalence of COVID-19 among NMD patients and the risk factors for its impact and severity during the first wave of the pandemic. Clinical data were collected from NMD-COVID-19 patients, between March 25, 2020 and May 11, 2020 in an anonymous survey carried out by expert physicians from the French Health Care Network Filnemus. Results: Physicians reported 84 patients, including: 34 with myasthenia gravis, 27 with myopathy and 23 with neuropathy. COVID-19 had no effect on NMD for 48 (58%) patients and 48 (58%) patients developed low COVID-19 severity. COVID-19 caused the death of 9 (11%) NMD patients. Diabetic patients were at greater risk of dying. Patients with diabetes, hypertension or severe forms of NMD had a higher risk of developing a moderate or severe form of COVID-19. In our cohort, corticosteroids and other immunosuppressants were not significantly associated with higher COVID-19 severity for acquired NMD. Conclusion: During this period, a small percentage of French NMD patients was affected by COVID-19 compared to the general French population and COVID-19 had a limited short-term effect on them. Diabetes, hypertension and a severe degree of NMD were identified as risk factors of unfavorable outcome following COVID-19. Conversely, in our cohort of patients with acquired NMD, corticosteroids or other immunosuppressants did not appear to be risk factors for more severe COVID-19.

---

Fichiers liés : BPH_OJRD_2021_Pisella.pdf

---

Source

---

• Type de publi. :
• Date de publi. : 25/10/2021
• Auteurs : Alain LécureuilPhilippe GuercheCôme EmmeneckerSophie Jasinski
• Organismes : Institut Jean-Pierre Bourgin - Sciences du végétal Institut Jean-Pierre Bourgin - Sciences du végétal Institut Jean-Pierre Bourgin - Sciences du végétal Institut Jean-Pierre Bourgin - Sciences du végétal

---

Source

---

• Type de publi. : Communication dans un congrès
• Date de publi. : 25/10/2021
• Auteurs : Alain LécureuilPhilippe GuercheCôme EmmeneckerSophie Jasinski
• Organismes : Institut Jean-Pierre Bourgin - Sciences du végétal Institut Jean-Pierre Bourgin - Sciences du végétal Institut Jean-Pierre Bourgin - Sciences du végétal Institut Jean-Pierre Bourgin - Sciences du végétal

---

Source

---

• Type de publi. : Article dans une revue
• Date de publi. : 21/10/2021
• Auteurs : Sven FrancquePierre BedossaVlad RatziuQuentin AnsteeElisabetta BugianesiArun SanyalRohit LoombaStephen HarrisonRozalina BalabanskaLyudmila MatevaNicolas LanthierNaim AlkhouriChristophe MorenoJörn SchattenbergDiana Stefanova-PetrovaLuisa VonghiaRégine RouzierMaeva GuillaumeAlexander HodgeManuel Romero-GómezPhilippe Huot-MarchandMartine BaudinMarie-Paule RichardJean-Louis AbitbolPierre BroquaJean-Louis JunienManal Abdelmalek
• Organismes : Universiteit Antwerpen = University of Antwerp Antwerp University Hospital [Edegem] Chercheur indépendant CHU Pitié-Salpêtrière [AP-HP] Newcastle University [Newcastle] Newcastle Upon Tyne Hospitals NHS Foundation Trust Università degli studi di Torino = University of Turin Virginia Commonwealth University University of California [San Diego] Radcliffe Department of Medicine [Oxford] Franco-czech Laboratory for clinical research on obesity Biomedicine Institute of Sevilla [Seville, Spain]
• Publié dans New England Journal of Medicine le 29/10/2020

---

Source